Fujii Takanari, Higaki Takashi, Tomita Hideshi, Nagaoka Kota, Yamaguchi Hideki, Shimizu Takeshi, Oyama Nobuo, Sasaki Takeshi, Asada Dai, Hata Yoshihito, Tarui Suguru, Miyahara Yoshinori, Ishino Kozo, Soga Takashi, Ota Masaaki
Pediatric Heart Disease and Adult Congenital Heart Disease Center, Showa University Hospital, Tokyo, Japan.
Department of Pediatrics, Ehime University Graduate School of Medicine, Matsuyama, Japan.
J Cardiol Cases. 2019 Aug 21;20(4):147-150. doi: 10.1016/j.jccase.2019.08.004. eCollection 2019 Oct.
We report the first case of transcatheter perimembranous ventricular septal defect (pmVSD) closure in Japan where none of existing devices for VSD closure has been approved. The pmVSD was successfully closed with first generation Amplatzer® duct occluder (ADO-I; St Jude Medical, St Paul, MN, USA). The procedure was performed under general anesthesia with transesophageal echocardiographic and fluoroscopic guidance. The left ventricular volume overload after the procedure was remarkably improved and no major complications occurred. ADO-I can be a safe and effective option for transcatheter pmVSD closure. The incidence of heart block may be less than reported with the original device. < Use of Amplatzer® duct occluder is effective in transcatheter perimembranous ventricular septal defect (pmVSD) closure in selected patients. It may be safer than original Amplatzer pmVSD occluder to avoid complete atrioventricular block.>.
我们报告了日本首例经导管膜周部室间隔缺损（pmVSD）封堵术，该国尚无用于室间隔缺损封堵的现有器械获得批准。使用第一代Amplatzer®动脉导管封堵器（ADO-I；美国圣保罗圣犹达医疗公司）成功封堵了pmVSD。手术在全身麻醉下进行，采用经食管超声心动图和荧光透视引导。术后左心室容量超负荷得到显著改善，未发生重大并发症。ADO-I可能是经导管pmVSD封堵的一种安全有效的选择。心脏传导阻滞的发生率可能低于原器械报告的发生率。<使用Amplatzer®动脉导管封堵器对选定患者经导管膜周部室间隔缺损（pmVSD）封堵有效。它可能比原Amplatzer pmVSD封堵器更安全，可避免完全性房室传导阻滞。>
